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APPENDIX B
Valorization
Since 2013, Maastricht University requires its doctoral theses to come equipped with a “Val-
orization Addendum”, with the intended goal of increasing the “visibility and societal impact”
of its research. Among the examples of such “value creation” are open source tools, software
and the process of “making models and systems available” (Maastricht University Board of
Deans, 2013). This chapter is submitted to comply with this requirement.
Computational models of the cardiac action potential (AP) can form the basis of multi-
scale models of cardiac physiology and pathophysiology (Southern et al., 2008). In the
past decades, several studies have shown how such models can be modified to include the
molecular changes caused by genetic defects or drugs, so that their effects on the cell, tissue,
and organ levels can be predicted (Chapter 8). The mechanistic insights and predictive
power these models provide is badly needed, as the link between such molecular changes
and arrhythmias is complex and still incompletely understood (Weiss et al., 2015).
Setting up multi-scale simulations can be a time consuming process and, even for cutting-
edge science, often involves reimplementing existing techniques. Having re-usable, model-
independent software tools can save time and effort, can make numerical methods available
to a wide audience, and can help to shift the focus of the experimenter from computational
aspects to biology. Chapter 3 of this thesis introduced Myokit, a tool for (multi-scale)
modeling of the cardiac AP. Myokit contains methods to create models of ionic currents
(possibly altered by drugs or mutations), to integrate them into models of the cellular AP,
and to use them in simulations of cardiac tissue. In addition, Myokit has support for model
import and export, removing the need for manual model (re-)implementation. Chapters 3,
5, and 7 contain examples of Myokit’s scientific use.
In this valorization addendum, we highlight examples of non-academic use of AP-model
based simulations. We then discuss how we have made Myokit, our tool for such work,
available to the community. Finally, we look at the first, promising, signs of early adoption
of Myokit outside of Maastricht University.
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AP-models have applications beyond academia
Simulations of the cardiac cellular AP have a long history in science, where they have been
used to investigate the basic principles of cardiac electrophysiology (see Chapter 2 and
Chapter 8). Sharing and promoting Myokit among an academic audience has an impact
on society, as it has the potential to accelerate scientific work via the sharing of methods
(included in Myokit) and models (using Myokit’s support for exchange languages such as
CellML, see Hedley et al., 2001). This type of knowledge dissemination is discussed in detail
in the introduction to Chapter 3. Outside of science, the predictive power of AP-model
based simulation is increasingly being recognized. The examples listed below show how
simulations can be used in risk stratification (clinical use), drug development (industrial
use), and regulation (governmental use).
Hoefen et al. (2012) showed that simulations of transmural repolarization prolongation can
be used to distinguish low-risk and high-risk mutations in LQT1-syndrome with increased
specificity and sensitivity. This provides a direct use of simulation in the optimization of clin-
ical treatment. Similar transmural simulations were used as the first example in Chapter 3.
Risk of inducing torsades de points is a common reason to reject drugs during development.
Cummins Lancaster and Sobie (2016) simulated the effect of several drugs on the human cel-
lular AP, and found that this provided more reliable predictions of their arrhythmogenicity
than existing in vitro assays. To increase the reliability of their predictions, they repeated
their simulations in multiple models of the AP, much like in the third example shown in
Chapter 3. The increasing interest of regulatory bodies to use mechanistic cardiac modeling
in drug safety testing is discussed in depth in a review by Davies et al. (2016). While Myokit
is aimed primarily at scientific users, it could easily be used outside of academia in pilot
projects, exploratory studies, prototyping, or as the inspiration for specialized commercial
software.
Myokit is available to the community
Since the start of its development, Myokit has been made available online. This has allowed
scientists outside of Maastricht to use it, has generated valuable feedback for its develop-
ment, and has promoted the visibility of multi-disciplinary biomedical research at Maastricht
University.
We have taken care to provide adequate documentation to enable external use. A PDF ver-
sion of Myokit’s documentation currently runs to 277 pages (although the same information
is more easily accessed via the Myokit website). In addition, the Myokit website contains
several examples of its use and further examples were provided with our recent publication
about the tool (Clerx et al., 2016). In 2014, we organized a workshop to introduce Myokit
to scientific users, which attracted more than 30 international participants.
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Figure B.1: Myokit development, publications and early adoption. Recent events include its first public
presentation (Clerx et al., 2014), the first time Myokit was mentioned in a peer-reviewed article by an
external group (Garny and Hunter, 2015), the first time it was used in a peer-reviewed article by an external
group, (Law and Levin, 2015) and publication of the article that formed the base of Chapter 3 (Clerx et al.,
2016).
Myokit is fully open-source and can be downloaded and used free-of-charge under the GNU
General Public License (GPL, see also http://myokit.org). In addition, Myokit itself is
based entirely on open-source components such as Python, NumPy/SciPy (Jones et al.,
2001), Matplotlib (Hunter, 2007) and Sundials (Hindmarsh et al., 2005). Combined with
an operating system such as GNU/Linux, this creates an entirely open-source environment,
available free of charge. In addition, Myokit can be run on Windows or OS/X (Apple).
Myokit is already being used outside of Maastricht
Myokit development started in December 2011 and it was first presented publicly in Septem-
ber 2014. The first peer-reviewed article discussing it in detail was published in January
2016. A brief timeline of its development and publication is provided in Fig. B.1 and an
extended version can be found on the Myokit website (http://myokit.org/changelog).
Given the time it takes to adopt a new work flow, perform research, and have it published,
it will take some time before Myokit’s success in the (scientific) community can be assessed.
Some preliminary data is presented below. First, Myokit has been downloaded over 600
times as of July 2016. But while some effort1 has been made to filter real users from auto-
mated downloads, this may not be an accurate statistic. Secondly, a mailing list was started
in January 2016 where users can receive updates and ask questions about Myokit, so far this
has 15 subscribed users (which is similar to older, more established tools like OpenCOR).
Another measure of Myokit’s visibility came in 2016, when its principal developer was elected
for a three-year term on the CellML editorial board2. However, the best feedback has come
in the form of personal communication and citations. Based on such feedback, we know of
at least three instances where Myokit has been used for teaching outside of Maastricht (at
both Bachelor and Master level, see http://myokit.org/publications). The first study
(by scientists other than the Myokit developers) using Myokit for simulations came in 2015,
1Filtering was applied by excluding any IP address with 20 or more downloads, excluding any downloads
with a ‘user-agent’ indicating an automated search rather than a human user and by requesting that search
engines do not download the tracked files.
2See https://www.cellml.org/about/news/cellml-editor-election-results-2016
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Figure B.2: The blue dots show locations where papers were published using Myokit. Green dots indicate
known Myokit users. Red dots indicate mentions of Myokit in papers about related software, while yellow
dots indicate universities where Myokit was used for teaching. Finally, the grey dot indicates Maastricht,
where Myokit was developed.
just before the first journal article describing Myokit was published (Law and Levin, 2015).
Three further publications, including two in high-ranking journals, emerged in 2016 and
early 2017 (Park et al., 2016; Boukhabza et al., 2016; Schmidt et al., 2017). Three more
publications refer to Myokit when comparing electrophysiology software, which further adds
to the visibility of Maastricht University in this field (Garny and Hunter, 2015; Castro et al.,
2016; Onal et al., 2016). Fig. B.2 shows the geographic locations of known early Myokit
usage and citations.
Conclusion
Multi-scale simulations based on models of the cardiac cellular AP are increasingly being
used outside of academia. We have developed Myokit, a tool for such simulations and made
it available online with a permissive license and extensive documentation. This has resulted
in early adoption and helped (1) to disseminate research done at Maastricht University to
a wider community and (2) to increase the world-wide visibility of Maastricht University’s
computational electrophysiological research.
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